ESO-ESSO Masterclass in Breast Cancer Surgery
30 ESCO credits
04.10.2014 - 07.10.2014
Ermatingen, Switzerland
MASTERCLASS
Description
Chairs: A. Costa, IT - M. Leidenius, FI - L. Wyld, UK
Scientific Coordinator: W. Gatzemeier, IT
The ESO-ESSO Masterclass in Breast Cancer Surgery is at the cutting edge of current concepts of surgical treatment of breast cancer. The focus of the Masterclass is on evidence-based clinical practice and technical aspects of breast cancer surgery, within a multidisciplinary approach. The programme includes state-of-the-art lectures, “meet the expert”- type workshops and case presentations and discussions aiming at facilitating the interaction between participants and Teachers.
AIMS AND OBJECTIVES
The Masterclass in Breast Cancer Surgery offers participants a qualified, comprehensive training to improve their knowledge and skills in the management, treatment and care in the field of breast cancer management.
Within the concept of a multidisciplinary approach attendees will improve in their skills in the totality of treatment of breast cancer and increase their confidence in the management of complex cases. Participants will better understand current best clinical practice and state of the art in breast cancer care.
The Masterclass will enable participants to implement evidence-based concepts and guidelines on the surgical treatment of breast cancer to individualize the care of their patients.
TEACHING FORMAT
The Masterclass in Breast Cancer Surgery is at the cutting edge of current concepts of surgical treatment of breast cancer. The focus of the Masterclass is on evidence-based clinical practice and technical aspects of breast cancer surgery, within a multidisciplinary approach. The programme offers plenary lectures regarding state-of-the-art clinical evaluation, treatments with reference to clinical guidelines which will conclude in take-home messages. The Clinical sessions will be complemented by Tumour Board discussions.
Furthermore, participants will deliver case presentations within small groups and discuss these with the chairmen and the faculty aiming at facilitating the interaction between participants and teachers.
All participants will reside at the course venue and participation is compulsory
throughout the course. The Masterclass will be entirely in English and fluency in English is mandatory for admission
TOPICS
• Skin and Nipple sparing mastectomy
• Excisional margins - do they really count?
• The use of nomograms in clinical practice
• Management of borderline lesions
• Breast surgery for stage IV patients
• Conservative surgery for local recurrence
• Multidisciplinary management of DCIS
• Impact of surgery on molecular subclasses of Breast Cancers
• Breast cancer during pregnancy
• Multifocal/multicentric BC
• SLNB before/after neoadjuvant chemotherapy
• RT and breast reconstruction
• Intraoperative RT
• Microinvasive BC
• Contralateral prophylactic mastectomy
• Management of axillary nodes: AMAROS and beyond
THE MASTERCLASS IS:
• 3-days residential educational event
• Full immersion in breast cancer surgery
• Clinically-oriented training
• Multidisciplinary
• International faculty of top experts delivering lectures
• Meet the expert workshops and case discussions
The Masterclass in |  | ||||
General information
ORGANISING SECRETARIAT
Ana Galán
Education Coordinator
European Society of Surgical Oncology (ESSO)
Avenue E. Mounier 83
1200 Brussels (Belgium)
e-mail: ana.galan@essoweb.org
Rita De Martini
European School of Oncology (ESO)
Via Turati, 29
20121 Milan (Italy)
e-mail: rdemartini@eso.net
ACCREDITATION
Application for CME accreditation has been made to the European Accreditation Council for Continuing Medical Education (EACCME®), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the application can be obtained from the organising secretariat.
Ana Galán
Education Coordinator
European Society of Surgical Oncology (ESSO)
Avenue E. Mounier 83
1200 Brussels (Belgium)
e-mail: ana.galan@essoweb.org
Rita De Martini
European School of Oncology (ESO)
Via Turati, 29
20121 Milan (Italy)
e-mail: rdemartini@eso.net
ACCREDITATION
Application for CME accreditation has been made to the European Accreditation Council for Continuing Medical Education (EACCME®), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the application can be obtained from the organising secretariat.
Faculty list
FACULTY
F. Cardoso, Breast Unit, Champalimaud Cancer Center, Lisbon, PT
A. Costa, European School of Oncology, Milan, IT
W. Gatzemeier, Breast Unit, Humanitas Cancer Center, Rozzano/Milan, IT
T. Kovacs, Breast Unit, Guy's and St. Thomas' NHS Foundation Trust, London, UK
M. Leidenius, Breast Surgery Unit, Helsinki University Central Hospital, FI
E.C. Moser, Breast Unit and Department of Radiation Oncology, Champalimaud Cancer Center, Lisbon, PT
P. Panizza, Department of Diagnostic Radiology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT
G. Pruneri, Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, IT
D. Rainsbury, Oncoplastic Breast Surgery, Royal Hampshire County Hospital, Winchester, UK
S. Suominen, Department of Plastic Surgery, Helsinki University Central Hospital, Helsinki, FI
M. Thill, Department of Gynecology and Obstetrics, Certified Breast Cancer Center, Agaplesion Markus, Frankfurt, DE
L. Wyld, Academic Unit of Surgical Oncology, University of Sheffield Medical School, Sheffield, UK
Programme
4 October
| Morning: Participants' arrival, airport transfers, registration | ||
| 14:15 | Warm-up session (3 groups with Chairs) | |
| 14:45 | Opening | |
| Multidisciplinary team of breast cancer: Why is it crucial? F. Cardoso, PT | ||
| Session 1: Screening - Prevention - Multidisciplinary management of DCIS and other high risk lesions | ||
15:05 | The role of the radiologist | |
15:25 | Classification and prognostic markers | |
15:45 | Surgical management of DCIS M. Leidenius, FI | |
16:05 | Radiation treatment of DCIS E.C. Moser, PT | |
| 16:25 | Coffee break | |
| Session 2: Microinvasive breast cancer and borderline lesions | ||
| 16:55 | Microinvasive breast cancer M. Leidenius, FI | |
| 17:15 | Pathology G. Pruneri, IT | |
| 17:35 | Tumour board: Sessions 1+2 | |
| 18:30 | End of daily programme | |
| 19:30 | Dinner | |
5 October
| Session 3: Breast conservative treatment (BCT) | ||
| 8:30 | Margins: What does really matter? M. Thill, DE | |
| 8:50 | Multifocal-multicentric disease and BCT | |
| 9:10 | Molecular subtypes and surgical approach | |
| 9:30 | Radiation treatment: Essentials in BCT | |
| 10:00 | Coffee break | |
Session 4: Locally advanced, recurrent and advanced breast cancer | ||
| 10:30 | Primary systemic therapy F. Cardoso, PT | |
| 11:00 | Surgical considerations and primary systemic therapy W. Gatzemeier, IT | |
| 11:20 | Surgery in locally advanced and stage IV breast cancer M. Leidenius, FI | |
| 11:50 | Surgical treatment after recurrent breast cancer W. Gatzemeier, IT | |
| 12:10 | Tumour board: Sessions 3+4 | |
| 13:00 | Lunch | |
| Session 5a: Breast cancer in young patients | ||
| 14:00 | Surgery in young women - What is different L. Wyld, UK | |
| 14:20 | Medical treatment in young women - What is different F. Cardoso, PT | |
| Session 5b: Management of high risk women | ||
| 14:40 | High risk women L. Wyld, UK | |
| 15:10 | Tumour board: Session 5 | |
| 16:00 | Coffee break | |
| Session 6: Workshop - Meet the expert 1 (small groups) case presentation (cases provided by participants) and pro/cons discussion | ||
| 18:30 | End of daily programme | |
| 19:30 | Dinner | |
6 October
| Session 7: Oncoplastic surgery | ||
| 8:30 | Oncoplastic breast conservation: Indications, techniques and outcomes D. Rainsbury, UK | |
| 9:00 | Tumour board: Session 7 | |
| Session 8: Mastectomy | ||
| 9:15 | Skin sparing and non-skin sparing T. Kovacs, UK | |
| 9:35 | Nipple sparing L. Wyld, UK | |
| 10:00 | Coffee break | |
| 10:30 | Prophylactic - bilateral and contralateral L. Wyld, UK | |
| Session 9: Breast reconstruction | ||
| 10:50 | Critical review of implant reconstruction D. Rainsbury, UK | |
| 11:10 | Current practice for implant based breast reconstruction: The role of ADMS and dermal sling to improve outcomes and patient satisfaction T. Kovacs, UK | |
| 11:30 | Flaps S. Suominen, FI | |
| 11:50 | Postmastectomy radiotherapy and reconstruction E.C. Moser, PT | |
| 12:10 | Tumor board: Sessions 8+9 | |
| 13:00 | Lunch | |
| Session 10: axillary management | ||
| 14:00 | SLNB before and after NACT T. Kovacs, UK | |
| 14:30 | IBCSG 23 - Z011 - AMAROS and beyond W. Gatzemeier, IT | |
| 15:00 | Axillary radiation treatment E.C. Moser, PT | |
| 15:30 | Nomograms M. Leidenius, FI | |
| 16:00 | Coffee break | |
| 16:30 | Tumour board: Session 10
| |
| Session 11: Workshop - Meet the expert 2 (small groups) case presentation (cases provided by participants) and pro/cons discussion | ||
| 18:30 | End of daily programme | |
| 19:30 | Dinner | |
7 October
| Session 12: Survivor problems | ||
| 8:30 | Surgical treatment of lymphedema S. Suominen, FI | |
| 8:50 | Endocrine issues M. Thill, DE | |
| 9:10 | Chronic pain M. Leidenius, FI | |
| 9:30 | Late breaking news | |
| 10:00 | Coffee break | |
| 10:30 | Learning assessment test | |
| 12:00 | Close | |
| Transfers and departure of participants | ||